CHINOOK THERAPEUTICS, INC. 4 SEC Filings

Filed On	Filing
11 Aug 2023	Form 4: Thomas Dolca, Director Returned 13,300 shares to the issuer · Disposed of 42,770 Stock Option (Right to Buy) (Disposition to Issuer) ($1.08M)
11 Aug 2023	Form 4: Oxtoby Andrew, Chief Commercial Officer Disposed of 160,000 Stock Option (Right to Buy) (Disposition to Issuer) ($2.91M) · Disposed of 40,000 Restricted Stock Units (Disposition to Issuer)
11 Aug 2023	Form 4: Krishnan Mahesh, Director Returned 1,275 shares to the issuer · Disposed of 26,600 Stock Option (Right to Buy) (Disposition to Issuer) ($619K) · Disposed of 4,401 Restricted Stock Units (Disposition to Issuer)
11 Aug 2023	Form 4: King Andrew James, Chief Scientific Officer Returned 19,157 shares to the issuer · Disposed of 491,139 Stock Option (Right to Buy) (Disposition to Issuer) ($13.1M) · Disposed of 74,688 Restricted Stock Units (Disposition to Issuer)
11 Aug 2023	Form 4: Griffin Michelle Renee, Director Returned 3,300 shares to the issuer · Disposed of 42,770 Stock Option (Right to Buy) (Disposition to Issuer) ($1.08M)
11 Aug 2023	Form 4: Greenman William Mariner, Director Returned 23,643 shares to the issuer · Disposed of 75,570 Stock Option (Right to Buy) (Disposition to Issuer)
11 Aug 2023	Form 4: Frohlich Tom, Chief Operating Officer Returned 150,777 shares to the issuer · Disposed of 437,640 Stock Option (Right to Buy) (Disposition to Issuer) ($10.9M) · Disposed of 66,449 Restricted Stock Units (Disposition to Issuer)
11 Aug 2023	Form 4: Dobmeier Eric, Director Returned 301,138 shares to the issuer · Disposed of 1,672,310 Stock Option (Right to Buy) (Disposition to Issuer) ($49.6M) · Disposed of 176,396 Restricted Stock Units (Disposition to Issuer)
11 Aug 2023	Form 4: Jerel Davis, Director Returned 3,482,220 shares to the issuer · Disposed of 42,770 Stock Option (Right to Buy) (Disposition to Issuer) ($1.08M)
11 Aug 2023	Form 4: Bjerkholt Eric, Chief Financial Officer Returned 39,371 shares to the issuer · Disposed of 338,288 Stock Option (Right to Buy) (Disposition to Issuer) ($7.92M) · Disposed of 62,917 Restricted Stock Units (Disposition to Issuer)
11 Aug 2023	Form 4: Azelby Robert, Director Disposed of 28,200 Stock Option (Right to Buy) (Disposition to Issuer) ($519K) · Disposed of 7,000 Restricted Stock Units (Disposition to Issuer)
11 Aug 2023	Form 4: Akkaraju Srinivas, Director Returned 5,165,188 shares to the issuer · Disposed of 42,770 Stock Option (Right to Buy) (Disposition to Issuer) ($1.08M)
01 Aug 2023	Form 4: King Andrew James, Chief Scientific Officer Received 3,333 shares by exercise or conversion · Sold 1,168 shares ($45.6K)
31 May 2023	Form 4: Greenman William Mariner, Director Received 3,300 shares by exercise or conversion · Sold 1,155 shares ($26.9K)
31 May 2023	Form 4: Akkaraju Srinivas, Director Received 3,300 shares by exercise or conversion
31 May 2023	Form 4: Haghighat Ross, Director Received 3,300 shares by exercise or conversion
31 May 2023	Form 4: Griffin Michelle Renee, Director Received 3,300 shares by exercise or conversion
31 May 2023	Form 4: Jerel Davis, Director Received 3,300 shares by exercise or conversion
31 May 2023	Form 4: Thomas Dolca, Director Received 3,300 shares by exercise or conversion
26 Apr 2023	Form 4: Dobmeier Eric, Director Received 25,000 shares by exercise or conversion ($10.5K) · Sold 23,800 shares ($514K) · Acquired 1,200 shares (Open Market Sale) ($26.7K)

Comments